17/04/20
The biotech company Solstar Pharma is currently available on the exempt market clients. Contact your representative to see if this investment opportunity is suitable for you. Recently, Solstar Pharma signed a global license and collaborative research agreement with the Japanese company GF Mille, for the development of the novel RNA drugs for the treatment of cancer and infectious diseases.
To learn more about this opportunity, please contact us at 514-875-9900 or make an appointment with one of our representatives.
